These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19524384)

  • 1. Risk of bleeding following hemorrhoidal banding in patients on antithrombotic therapy.
    Nelson RS; Thorson AG
    Gastroenterol Clin Biol; 2009; 33(6-7):463-5. PubMed ID: 19524384
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis.
    Nelson RS; Ewing BM; Ternent C; Shashidharan M; Blatchford GJ; Thorson AG
    Am J Surg; 2008 Dec; 196(6):994-9; discussion 999. PubMed ID: 19095121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding complications in dermatologic surgery.
    Hurst EA; Yu SS; Grekin RC; Neuhaus IM
    Semin Cutan Med Surg; 2007 Mar; 26(1):40-6. PubMed ID: 17349562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac surgery in patients on antiplatelet and antithrombotic agents.
    Woo YJ
    Semin Thorac Cardiovasc Surg; 2005; 17(1):66-72. PubMed ID: 16104363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bleeding complications after treatment with antithrombotic agents after acute coronary syndrome].
    Kristensen SD
    Ugeskr Laeger; 2006 Sep; 168(38):3201. PubMed ID: 17026890
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antithrombotic-treated patient].
    Nielsen JD; Rasmussen HM; Husted SE
    Ugeskr Laeger; 2006 Dec; 168(49):4296-9. PubMed ID: 17164056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
    Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
    Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
    Patti G; Di Sciascio G
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding.
    Schulman S; Spencer FA
    J Thromb Haemost; 2010 Apr; 8(4):641-50. PubMed ID: 20059668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic agents].
    Yamazaki M; Uchiyama S
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():231-8. PubMed ID: 23156514
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies.
    Rao SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):60C-3C. PubMed ID: 19695364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases.
    Niemi T; Silvasti-Lundell M; Armstrong E; Hernesniemi J
    Acta Neurochir (Wien); 2009 Oct; 151(10):1289-94. PubMed ID: 19513580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary haemorrhage after rubber band ligation of haemorrhoids in patients taking clopidogrel--a cautionary note.
    Beattie GC; Rao MM; Campbell WJ
    Ulster Med J; 2004 Nov; 73(2):139-41. PubMed ID: 15651778
    [No Abstract]   [Full Text] [Related]  

  • 19. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antithrombotic agents and the risk of bleeding.
    van der Linden J
    Transfusion; 2008 Mar; 48(1 Suppl):47S-50S. PubMed ID: 18302582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.